Stock comparison
Becton, Dickinson and
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BDX
Becton, Dickinson and
Market cap
$53.46B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BDX | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 49D | 77B | LMAT |
| Benjamin Graham | 57C | 89A | LMAT |
| Philip Fisher | 36D | 81C | LMAT |
| Peter Lynch | 15F | 67B | LMAT |
| Joel Greenblatt | 40D | 56D | LMAT |
| Charlie Munger | 39D | 68D | LMAT |
| Terry Smith | 39D | 69D | LMAT |
Side-by-side metrics
| Metric | BDX | LMAT |
|---|---|---|
| Market cap | $53.46B | $2.23B |
| P/E (TTM) | 35.3x | 37.1x |
| EV/EBIT | 26.5x | 36.6x |
| ROIC (TTM) | 4.1% | 9.43% |
| Gross margin | 46.48% | 72.39% |
| Net margin | 5.33% | 24.35% |
| Revenue CAGR 5y | 3.37% | 12.75% |
| EPS CAGR 5y | -4.15% | 19.04% |
| Debt / Equity | 0.7x | 0.5x |
| Dividend yield | 2.45% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BDX leads on
- Market cap$53.46Bvs $2.23B+96%
- Dividend yield2.45%vs 0.84%+66%
- EV/EBIT26.5xvs 36.6x+28%
LMAT leads on
- EPS CAGR 5y19.04%vs -4.15%+122%
- Net margin24.35%vs 5.33%+78%
- Revenue CAGR 5y12.75%vs 3.37%+74%
- ROIC (TTM)9.43%vs 4.1%+57%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.